Fig. 2From: A phase II single arm study of Nivolumab with stereotactic Ablative radiation Therapy after induction chemotherapy in CHOlangiocarcinoma (NATCHO)Schema of synergistic effect of SBRT and immunotherapy (Adapted from Kreidieh et al. [57])Back to article page